NDC 25682-001 – Soliris
Eculizumab 300 mg/30mL · Injection, Solution, Concentrate · Intravenous
Product NDC25682-001
Product details
- Brand name
- Soliris
- Generic name
- Eculizumab
- Labeler
- Alexion Pharmaceuticals Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA125166
- Marketed since
- April 2, 2007
- Listing expires
- December 31, 2027
- Pharmacologic class
- Complement Inhibitor
Active ingredients
- Eculizumab 300 mg/30mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 25682-001-01 | 1 VIAL in 1 CARTON (25682-001-01) / 30 mL in 1 VIAL | Apr 2, 2007 |
Recalls mentioning this NDC
- D-1512-2014 Aug 13, 2014 · Class I
Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition. - D-1049-2014 Feb 5, 2014 · Class I
Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.